1. Home
  2. blog

Secondary head-to-head comparison: LIFU vs rTMS for motor recovery after stroke

A PLOS One secondary analysis of a randomized trial (n=50) found similar short‑term Fugl–Meyer and Barthel gains after subacute stroke with LIFU or rTMS, while LIFU produced larger change‑from‑baseline motor improvements and increased prefrontal fALFF on fNIRS.

25 Apr 2026

Review details mechanisms, clinical uses and limits of tACS across neuropsychiatric disorders

A review led by Prof. Hongxing Wang (Chinese Medical Journal, 5 Apr 2026) summarizes proposed mechanisms and reported clinical uses of tACS across depression, Alzheimer's, schizophrenia and stroke, and calls for larger randomized trials and closed-loop protocols.

23 Apr 2026

A “muddy intervention”: taVNS yields mixed outcomes for people with Long COVID

People with Long COVID are trying ear-based vagus nerve stimulation at home with mixed outcomes. Small trials, a 2024 survey and ongoing studies show both benefit for some users and reports of crashes and adverse effects; experts advise caution and physician oversight.

23 Apr 2026

Nature Reviews Bioengineering publishes framework for digital biomarkers in neurodegenerative disease

A Stanford-led review published 23 April 2026 in Nature Reviews Bioengineering presents a three‑pillar framework for digital biomarkers in neurodegenerative disease, highlights mature motor measures (like gait via IMUs) and lists gaps: small studies, interoperability, equity and cost-effectiveness.

23 Apr 2026

Chaotic heartbeat patterns track cognitive brain activity better than conventional HRV, Kyoto researchers report

Kyoto University researchers found that chaos-based measures of heart-rate variability change with cognitive task load while conventional HRV does not, suggesting a noninvasive signal of brain–heart coupling (Scientific Reports, 2026).

23 Apr 2026

Medtronic launches Adaptive Deep Brain Stimulation system in India

Medtronic has introduced its Adaptive Deep Brain Stimulation (aDBS) system in India, using US FDA‑approved BrainSense sensing to adjust stimulation in real time for Parkinson’s patients. The company says the device aims to improve symptom control and extend battery life amid a rising Parkinson’s burden in India.

23 Apr 2026
1 2 3 4 5 6 7 8 9 10 ... 20 21

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

Archives